BOIVF yields 1.55% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, BOIVF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BOIVF + MRK for your $10,000?
Bolloré SE engages in the transportation and logistics, communications, and electricity storage solutions businesses in Asia, Africa, the Americas, the Asia-Pacific, and internationally. It operates through Transportation and Logistics, Oil Logistics, Communications, and Electricity Storage and Systems segments. The company offers freight forwarding, railroad, and port services; and distributes and warehouses oil products. It also provides advertising, and communication consulting services; owns and publishes Cnews, a French daily newspaper; provides ticketing and venue services; acts as a pay-TV operator; and operates Mac-Mahon cinema theaters. Further, it develops batteries based on Lithium Metal Polymer technology for use in electric buses, as well as in stationary applications; energy storage solutions; and plastic films for capacitors, and shrink-wrap packaging films, as well as offers Bluebus electric buses. Additionally, the company designs, products, and markets solutions for passenger air and rail transport networks; integrates identification, tracking, and mobility solutions for logistics contractors, industry, and transport; develops terminals, electric charging points, and identification and geolocalization systems; operates shuttles; offers Bluecar electric vehicles and digital transformation solutions; provides equipment to control pedestrian and vehicles; and develops, deploys, and operates point-to-point car sharing solutions. The company was founded in 1822 and is based in Puteaux, France. Bolloré SE is a subsidiary of Financière de l'Odet SE.
Full BOIVF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.